This Article
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Web of Science (29)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Neumann, P. J.
* Articles by Kosik, K. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Neumann, P. J.
* Articles by Kosik, K. S.
Related Collections
* Chronic Care
* Public Opinion

DataWatch

Public Attitudes About Genetic Testing For Alzheimer’s Disease

Peter J. Neumann, James K. Hammitt, Curt Mueller, Howard M. Fillit, Jerrold Hill, Nii A. Tetteh and Kenneth S. Kosik

In a general population survey (N = 314), 79 percent of respondents stated that they would take a hypothetical genetic test to predict whether they will eventually develop Alzheimer’s disease. The proportion fell to 45 percent for a "partially predictive" test (which had a one in ten chance of being incorrect). Inclination to obtain testing was similar across age groups. Respondents were willing to pay $324 for the completely predictive test. Respondents stated that if they tested positive, they would sign advance directives (84 percent), get their finances in order (74 percent), and purchase long-term care insurance (69 percent). Only a third of respondents expressed concern about confidentiality. The results suggest that people value genetic testing for personal and financial reasons, but they also underscore the need to counsel potential recipients carefully about the accuracy and implications of test information.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
R. C. Green, J. S. Roberts, L. A. Cupples, N. R. Relkin, P. J. Whitehouse, T. Brown, S. L. Eckert, M. Butson, A. D. Sadovnick, K. A. Quaid, et al.
Disclosure of APOE Genotype for Risk of Alzheimer's Disease
N. Engl. J. Med., July 16, 2009; 361(3): 245 - 254.
[Abstract] [Full Text] [PDF]


Home page
Public Understanding of ScienceHome page
J. D. Miller
Public Understanding of, and Attitudes toward, Scientific Research: What We Know and What We Need to Know
Public Understanding of Science, July 1, 2004; 13(3): 273 - 294.
[Abstract] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
S. J. Cutler and L. G. Hodgson
To test or not to test: Interest in genetic testing for Alzheimer's disease among middle-aged adults
American Journal of Alzheimer's Disease and Other Dementias, January 1, 2003; 18(1): 9 - 20.
[Abstract] [PDF]